Latest Nyse News

Page 7 of 26
Regions Financial expects fourth-quarter net interest income to rise 1% to 2% sequentially, while third-quarter adjusted earnings reached US$622 million. The bank also reported improving non-performing loans and net charge-offs, but flagged interest-rate and commercial credit risks that remain central to its outlook.
Victor Sage
Victor Sage
5 Nov 2026
Oracle has completed a sizeable capital raising combining US$10 billion of notes with the issue of 86.2 million common shares. The company has not yet specified how the proceeds will be divided between investment, debt repayment, acquisitions, dividends or buybacks.
Sophie Babbage
Sophie Babbage
5 Nov 2026
CF Industries delivered stronger third-quarter earnings and cash generation as nitrogen prices and volumes improved, while construction began on its US$3.7 billion Blue Point One project. The result was helped by favourable market conditions, lower realised gas costs and a US$62 million business interruption insurance recovery.
Victor Sage
Victor Sage
5 Nov 2026
Atmos Energy has forecast higher fiscal 2027 earnings, a larger capital programme and a 9% increase in its annual dividend. The natural gas distributor will also combine its chair and chief executive roles after Kim Cocklin’s retirement.
Maxwell Dee
Maxwell Dee
5 Nov 2026
STERIS delivered 9% second-quarter revenue growth and lifted its fiscal 2027 adjusted EPS outlook, helped partly by tariff refunds. Life Sciences led the operating gains, while weaker cash flow and a new restructuring plan add important qualifications.
Ada Torres
Ada Torres
5 Nov 2026
HP has turned to former GSK chief Emma Walmsley to lead the company from January, handing her a compensation package featuring a US$30 million inducement equity award. Interim CEO Bruce Broussard will become chair as the company prepares a significant leadership reset.
Sophie Babbage
Sophie Babbage
5 Nov 2026
MetLife delivered its highest quarterly adjusted earnings per share, supported by stronger investment income, broad-based volume growth and favourable underwriting. The result also came with a sharp fall in reported book value per share and a sizeable boost from derivative gains.
Victor Sage
Victor Sage
5 Nov 2026
Edwards Lifesciences delivered stronger-than-expected third-quarter growth and lifted its full-year 2026 outlook, led by a sharp rise in mitral and tricuspid therapies. A US$220.2 million impairment charge remains a notable counterpoint to the upbeat operating performance.
Ada Torres
Ada Torres
5 Nov 2026
Eversource Energy narrowed its 2026 recurring earnings guidance after third-quarter GAAP profit fell, while a $26.5 billion investment plan and unresolved regulatory exposures shape the utility’s next phase. The guidance midpoint rose to US$4.66 per share despite lower year-to-date reported earnings.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Aflac’s third-quarter GAAP earnings plunged after a US$1.1 billion investment loss tied largely to portfolio repositioning, masking a more resilient operating result. The insurer raised its Aflac Japan margin outlook and outlined a potential US$1 billion capital release through reinsurance.
Victor Sage
Victor Sage
5 Nov 2026
Albemarle delivered a sharp third-quarter rebound, with adjusted EBITDA reaching US$645.5 million as higher lithium pricing and productivity gains outweighed lower Energy Storage volumes. The company also raised its Specialties outlook and cut planned 2026 capital spending, while flagging weaker fourth-quarter Energy Storage results.
Victor Sage
Victor Sage
5 Nov 2026
Amcor has lowered its six-month adjusted earnings outlook after higher energy and distribution costs offset volume growth and Berry acquisition synergies. Sales rose 7%, but adjusted EBITDA slipped, free cash flow deteriorated sharply and net debt increased.
Maxwell Dee
Maxwell Dee
5 Nov 2026

Browse the archive

Full archive